期刊文献+

非经典抗精神病药作用机制及药物发现展望 被引量:7

Action mechanism of atypical antipsychotics and vista of drug discovery
下载PDF
导出
摘要 精神疾病严重危害人类健康。近10年来,非经典抗精神病药成为治疗精神分裂症的第二代药物。本文综述了非经典抗精神病药物可能的作用机制,并基于其结构特点及作用机制对该类药物进行分类和新型结构设计,为新一代高效低不良反应的非经典抗精神病药物分子的设计提供思路。 In the past 10 years, atypical antipsychotics were developed to be the second generation of medicine without extrapyramidal symptoms side effects to treat schizophrenia. This paper summarizes the structural feature, therapeutic effect of several representative atypical antipsychotics and their binding mechanism with target receptors at molecular levels. In addition, it also classifies atypical antipsychotics, based on their binding mechanism with target receptors. Finally a new clue for drug design and discovery of novel atypical antipsychotics with less side effects was provided.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2008年第6期470-476,共7页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金资助项目(20702009) 中国博士点新教师基金资助课题(20070246092)~~
关键词 抗精神病药 精神分裂症 受体 多巴胺 受体 血清素 antipsychotics schizophrenia receptors,dopamine receptors, serotonin
  • 相关文献

参考文献36

  • 1Blin O. A comparative review of new antipsychotics [ J ]. Can J Psychiatry, 1999, 44(3) :235 -244.
  • 2Di Lorenzo R, Tondelli G, Genedani S. Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients [J]. Int J Neuropsychopharmacol, 2001, 4(2) :135 - 137.
  • 3Toro CT, Deakin JFW. Adult neurogenesis and schizophrenia: a window on abnormal early brain development[ J] ? Schizophr Res, 2007, 90(1 -3) :1 -14.
  • 4Abi-Dargham A, Laruelle M. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies[ J]. Eur Psychiatry, 2005, 20 ( 1 ) : 15 - 27.
  • 5Butini S, Campiani G, Angelis MD, Fattorusso C, Nacci V, Fiorini I. Novel antipsychotic agents: recent advances in the drug treatment of schizophrenia[ J ]. Expert Opin Ther Patent, 2003, 13(4) : 425 -448.
  • 6Tandon R, Jibson MD. Efficacy of newer generation antipsychotics in the treatment of schizophrenia[J]. Psychoneuroendocrinology, 2003, 28(Suppl 1 ):9-26.
  • 7Littrell K, Peabody CD, Littrell SH. Olanzapine: a new atypical antipsychotic[ J]. J Psychosoc Nurs Merit Health Serv, 1996, 34 (8) :41 -46.
  • 8Liegeois JF, Ichikawa J, Mehzer HY. 5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner [ J ]. Brain Res, 2002, 947 ( 2 ) :157 -165.
  • 9Aghajanian GK, Marek GJ. Serotonin model of schizophrenia: emerging role of glutamate mechanisms [ J ]. Brain Res Brain Res Rev, 2000, 31(2 -3) :302 -312.
  • 10Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission [ J ]. Pharmacol Ther, 2007, 113(2) :296 -320.

共引文献3

同被引文献49

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部